Detalles de la búsqueda
1.
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-298067
2.
Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-288555
3.
Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-273920
4.
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-214759
5.
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-140871
6.
Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-109157
7.
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-435863
8.
Evolution of Antibody Immunity to SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-367391
9.
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-092619
10.
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-493121
11.
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-515932
12.
Bispecific antibody prevents SARS-CoV-2 escape and protects mice from disease
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-427567
Resultados
1 -
12
de 12
1
Próxima >
>>